Acute bronchodilator responsiveness to tiotropium in postinfectious bronchiolitis obliterans in children

Chest

Volumn 144, Issue 3, 2013, Pages 974-980

  Teixeira, Mariângela F C ^a   Rodrigues, Joaquim C ^a   Leone, Claudio ^a   Adde, Fabíola V ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; TIOTROPIUM BROMIDE;

ADOLESCENT; AIRWAY CONDUCTANCE; AIRWAY RESISTANCE; ARTICLE; BRONCHIOLITIS OBLITERANS; BRONCHODILATATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; FEMALE; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION; MALE; PLETHYSMOGRAPHY; POSTINFECTIOUS BRONCHIOLITIS OBLITERANS; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESIDUAL VOLUME; SCHOOL CHILD; SPIROMETRY; TOTAL LUNG CAPACITY; TREATMENT OUTCOME;

EID: 84884332285     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-2280     Document Type: Article

References (40)

1. Hardy KA, Schidlow DV, Zaeri N. Obliterative bronchiolitis in children. Chest. 1988 ; 93 (3): 460-466.
2. Chang AB, Masel JP, Masters B. Post-infectious bronchiolitis obliterans: clinical, radiological and pulmonary function sequelae. Pediatr Radiol. 1998 ; 28 (1): 23-29.
3. Zhang L, Irion K, Kozakewich H, et al. Clinical course of postinfectious bronchiolitis obliterans. Pediatr Pulmonol. 2000; 29 (5): 341-350.
4. Kurland G, Michelson P. Bronchiolitis obliterans in children. Pediatr Pulmonol. 2005 ; 39 (3): 193-208.
5. Smith KJ, Fan LL. Insights into post-infectious bronchiolitis obliterans in children. Thorax. 2006 ; 61 (6): 462-463.
6. Moonnumakal SP, Fan LL. Bronchiolitis obliterans in children. Curr Opin Pediatr. 2008 ; 20 (3): 272 - 278.
7. Colom AJ, Teper AM. Clinical prediction rule to diagnose post-infectious bronchiolitis obliterans in children. Pediatr Pulmonol. 2009 ; 44 (11): 1065-1069.
8. Fischer GB, Sarria EE, Mattiello R, Mocelin HT, Castro-Rodriguez JA. Post infectious bronchiolitis obliterans in children. Paediatr Respir Rev. 2010 ; 11 (4): 233-239.
9. Champs NS, Lasmar LM, Camargos PA, Marguet C, Fischer GB, Mocelin HT. Post-infectious bronchiolitis obliterans in children. J Pediatr (Rio J). 2011 ; 87 (3): 187-198.
10. Teper AM, Kofman CD, Maffey AF, Vidaurreta SM. Lung function in infants with chronic pulmonary disease after severe adenoviral illness. J Pediatr. 1999 ; 134 (6): 730-733.
11. Dezateux C, Fletcher ME, Dundas I, Stocks J. Infant respiratory function after RSV-proven bronchiolitis. Am J Respir Crit Care Med. 1997 ; 155 (4): 1349-1355.
12. Jones MH, Delfi m ML, Kallfelz ML, Vitola L, Pitrez PMC, Stein R. Pulmonary function in infants with post-infectious bronchiolitis obliterans [abstract]. In: ATS International Conference 2002; Atlanta, GA, 2002. p. A673.
13. Colom AJ, Maffey AF, Navarra F, Teper A. Pulmonary Function in children with post-viral chronic pulmonary disease [abstract]. In: ATS International Conference 2002; Atlanta, GA, 2002. p. A159.
14. Kim CK, Kim SW, Kim JS, et al. Bronchiolitis obliterans in the 1990s in Korea and the United States. Chest. 2001 ; 120 (4): 1101-1106.
15. Aguerre V, Castaños C, Pena HG, Grenoville M, Murtagh P. Postinfectious bronchiolitis obliterans in children: clinical and pulmonary function fi ndings. Pediatr Pulmonol. 2010 ; 45 (12): 1180-1185.
16. Mattiello R, Mallol J, Fischer GB, Mocelin HT, Rueda B, Sarria EE. Pulmonary function in children and adolescents with postinfectious bronchiolitis obliterans. J Bras Pneumol. 2010 ; 36 (4): 453-459.
17. Mattiello R, Sarria EE, Stein R, et al. Functional capacity assessment in children and adolescents with post-infectious bronchiolitis obliterans. J Pediatr (Rio J). 2008; 84(4): 337-343.
18. Brusasco V. Reducing cholinergic constriction: the major reversible mechanism in COPD. Eur Respir Rev. 2006 ; 15 (99): 32-36.
19. Keating GM. Tiotropium bromide inhalation powder: a review of its use in the management of chronic obstructive pulmonary disease. Drugs. 2012 ; 72 (2): 273-300.
20. Barnes PJ. The role of anticholinergics in chronic obstructive pulmonary disease. Am J Med. 2004; 117(suppl 12A): 24S-32S.
21. Gross NJ. Tiotropium bromide. Chest. 2004; 126(6): 1946-1953.
22. Donohue JF, van Noord JA, Bateman ED, et al. A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol. Chest. 2002 ; 122 (1): 47-55.
23. Casaburi R, Mahler DA, Jones PW, et al. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J. 2002 ; 19 (2): 217-224.
24. Tashkin D, Kesten S. Long-term treatment benefi ts with tiotropium in COPD patients with and without short-term bronchodilator responses. Chest. 2003 ; 123 (5): 1441-1449.
25. Anzueto A, Tashkin D, Menjoge S, Kesten S. One-year analysis of longitudinal changes in spirometry in patients with COPD receiving tiotropium. Pulm Pharmacol Ther. 2005 ; 18 (2): 75-81.
26. Vincken W, Van Noord JA, Greefhorst AP, et al. Improved health outcomes in patients with copd during one year's treatment with tiotropium. Eur Respir J. 2002 ; 19 (2): 209-216.
27. Casaburi R, Conoscenti CS. Lung function improvements with once-daily tiotropium in chronic obstructive pulmonary disease. Am J Med. 2004 ; 117 (suppl 12A): 33S-40S.
28. Casaburi R, Briggs DD Jr, Donohue JF, Serby CW, Menjoge SS, Witek TJ Jr ; The US Tiotropium Study Group. The spirometric effi cacy of once-daily dosing with tiotropium in stable COPD: a 13-week multicenter trial. Chest. 2000 ; 118 (5): 1294-1302.
29. Tashkin DP, Celli B, Senn S, et al; UPLIFT Study Investigators. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008 ; 359 (15): 1543-1554.
30. Rodrigo GJ, Castro-Rodriguez JA, Nannini LJ, Plaza Moral V, Schiavi EA. Tiotropium and risk for fatal and nonfatal cardiovascular events in patients with chronic obstructive pulmonary disease: systematic review with meta-analysis. Respir Med. 2009 ; 103 (10): 1421-1429.
31. Kaplan A. Effect of tiotropium on quality of life in COPD: a systematic review. Prim Care Respir J. 2010 ; 19 (4): 315-325.
32. Troosters T, Weisman I, Dobbels F, Giardino N, Valluri SR. Assessing the impact of tiotropium on lung function and physical activity in GOLD Stage II COPD patients who are naïve to maintenance respiratory therapy: a study protocol. Open Respir Med J. 2011 ; 5 : 1-9.
33. Celli B, ZuWallack R, Wang S, Kesten S. Improvement in resting inspiratory capacity and hyperinfl ation with tiotropium in COPD patients with increased static lung volumes. Chest. 2003 ; 124 (5): 1743-1748.
34. O'Donnell DE, Flüge T, Gerken F, et al. Effects of tiotropium on lung hyperinfl ation, dyspnoea and exercise tolerance in COPD. Eur Respir J. 2004 ; 23 (6): 832-840.
35. Miller MR, Hankinson J, Brusasco V, et al ; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005; 26(2): 319-338.
36. Wanger J, Clausen JL, Coates A, et al. Standardisation of the mea surement of lung volumes. Eur Respir J. 2005 ; 26 (3): 511-522.
37. Polgar G, Promadhat V. Pulmonary Function Testing in Children: Techniques and Standards. Philadelphia, PA: Saunders; 1971.
38. Quanjer PH, Stocks J, Polgar G, Wise M, Karlberg J, Borsboom G. Compilation of reference values for lung function measurements in children. Eur Respir J Suppl. 1989 ; 4 (suppl): 184S-261S.
39. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005 ; 26 (5): 948-968.
40. Barisione G, Bacigalupo A, Crimi E, Brusasco V. Acute bronchodilator responsiveness in bronchiolitis obliterans syndrome following hematopoietic stem cell transplantation. Chest. 2011 ; 139 (3): 633-639.